Table 1.
Analysis of ELISA reactivity of T-mVLPs with DENV serotype-specific mAbs.
| mAb | Serotype specificity | Epitope Specificity | ELISA OD450 nm | ||||
|---|---|---|---|---|---|---|---|
| E1 VLPs | E2 VLPs | E3 VLPs | E4 VLPs | T-mVLPs | |||
| E29 | DENV-1 | EDIII | 1.87 | 0.03 | 0.09 | 0.14 | 1.08 |
| 3H5 | DENV-2 | EDIII (FG loop of LR) | 0.03 | 2.12 | 0.02 | 0.02 | 1.25 |
| 8A1 | DENV-3 | EDIII (A strand, FG loop of LR) | 0.02 | 0.01 | 0.91 | 0.01 | 0.85 |
| E1 | EDIII (C-C’ loop) | 0.04 | 0.03 | 3.43 | 0.02 | 3.39 | |
| E3 | EDI/II | 0.13 | 0.03 | 2.90 | 0.02 | 2.04 | |
| E4 | 0.12 | 0.04 | 3.18 | 0.03 | 2.15 | ||
| E29 | DENV-4 | EDIII (F and G strands) | 0.04 | 0.04 | 0.03 | 2.80 | 2.23 |
| E40 | EDIII (A, F and G strands) | 0.01 | 0.01 | 0.01 | 3.23 | 2.68 | |
| E42 | E | 0.03 | 0.02 | 0.02 | 2.10 | 2.70 | |
| E43 | 0.02 | 0.02 | 0.02 | 2.15 | 1.95 | ||
Indirect ELISA was performed using E1 VLPs, E2 VLPs, E3 VLPs, E4 VLPs or T-mVLPs as coating antigens. Bound VLPs were detected using DENV-1 mAb E2926, DENV-2 mAb 3H535, DENV-3 mAbs E1, E3, E436 and 8A137, or DENV-4 mAbs E29, E42 and E4339. Mutational studies have identified specific aa residues recognising many of these mAbs. DENV-2 mAb 3H5 binds aa residues in FG loop of EDIII-LR38, DENV-3 mAb E1 binds G340 of C-C’ loop in EDIII36, DENV-4 mAb E29 binds to Y377 (F strand) and H390 (G strand) in the vicinity of EDIII-LR39 and DENV-4 mAb E40 binds K310 (A strand), D375, Y377 (F strand) and H390, F392 (G strand) in the vicinity of EDIII-LR39. Underlined ELISA OD450 nm values indicate the serotype-specificity of the mAbs used to probe T-mVLPs. Data shown are from one of two separate experiments. Note: This assay was not optimised for quantitation of the relative proportion of the different E proteins in the T-mVLPs. Differences in ELISA reactivity of a given mAb between the T-mVLPs and the cognate monovalent E VLPs may reflect subtle differences in the accessibility of the EDIII epitopes in the tetravalent versus the monovalent VLPs. However, meaningful inter-serotypic comparison of reactivity between mAbs is precluded as each binds to distinct and unique epitope(s) of different serotypes, presumably with characteristic binding affinities.